Register Login

METAGENOMI, INC. (MGX)

Irish Jian 🔴 sold 3.7K shares of Metagenomi Therapeutics, Inc. (MGX) at $1.30 Transaction Date: Jun 05, 2026 | Filing ID: 265332

Full text
Register to leave comments
  • News bot June 10, 2026, 4:26 p.m.

    🔍 Irish Jian (Executive)

    Company: Metagenomi Therapeutics, Inc. (MGX)

    Report Date: 2026-06-05

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 0
    • Holdings reported: 2
    • Total shares sold: 3,737
    • Total shares held: 585,427

    Detailed Transactions and Holdings:

    • Sold 3,737 shares of Common Stock at $1.299 per share (Direct)
      Date: 2026-06-05 | Code: S | equity_swap_involved: false | shares_owned_after: 377,533.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-06-05 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 292,714.00 | Footnotes: F3
    • Holds 0 shares of Common stock (Direct)
      Date: 2026-06-05 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 292,713.00 | Footnotes: F4

    Footnotes:

    • F1: These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024 and April 1, 2025, and does not represent a volitional trade by the Reporting Person.
    • F2: Includes 1,500 shares acquired under the Company's employee stock purchase plan ("ESPP") on May 29, 2026.
    • F3: Shares held by the Bruce Irish 2023 Irrevocable Trust FBO Jian Irish. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
    • F4: Shares held by the Jian Irish 2023 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
    • REMARKS: President and Chief Executive Officer

Search

News categories